1. Droxicam and hepatotoxicity – suspension of marketing authorizations recommended;Anonymous;Pharmaceut Newsl,1995
2. Bromfenac withdrawal. United States of America;Anonymous;WHO Drug Inform,1998
3. Withdrawal of medicinal products containing ebrotidine: liver toxicity;Anonymous;WHO Inform Exchange Syst,1998
4. Withdrawal of tolcapone (Tasmar);Curr Probl Pharmacovigil,1999
5. Trovafloxacin and alatrofloxacin – suspension and warnings: hepatotoxicity;Anonymous;WHO Inform Exchange Syst,1999